| Condition | Indicated | Relationship Strength | Studies | Trials |
|---|
Malignant Melanoma
[description not available] | 0 | 3.43 | 2 | 0 |
Cancer of Skin
[description not available] | 0 | 3.33 | 1 | 0 |
Melanoma
A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445) | 0 | 3.43 | 2 | 0 |
Skin Neoplasms
Tumors or cancer of the SKIN. | 0 | 3.33 | 1 | 0 |
Bone Cancer
[description not available] | 0 | 3.18 | 5 | 0 |
Androgen-Independent Prostatic Cancer
[description not available] | 0 | 2.21 | 1 | 0 |
Bone Neoplasms
Tumors or cancer located in bone tissue or specific BONES. | 0 | 3.18 | 5 | 0 |
Prostatic Neoplasms, Castration-Resistant
Tumors or cancer of the PROSTATE which can grow in the presence of low or residual amount of androgen hormones such as TESTOSTERONE. | 0 | 2.21 | 1 | 0 |
Breast Cancer
[description not available] | 0 | 7.75 | 3 | 0 |
Cancer of Lung
[description not available] | 0 | 3.16 | 5 | 0 |
Angiogenesis, Pathologic
[description not available] | 0 | 2.08 | 1 | 0 |
Breast Neoplasms
Tumors or cancer of the human BREAST. | 0 | 2.75 | 3 | 0 |
Lung Neoplasms
Tumors or cancer of the LUNG. | 0 | 3.16 | 5 | 0 |
Cancer of Prostate
[description not available] | 0 | 2.77 | 3 | 0 |
Prostatic Neoplasms
Tumors or cancer of the PROSTATE. | 0 | 2.77 | 3 | 0 |
Disease Models, Animal
Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. | 0 | 2.76 | 3 | 0 |
Lymph Node Metastasis
[description not available] | 0 | 2.47 | 2 | 0 |
Autoimmune Disease
[description not available] | 0 | 3.04 | 1 | 0 |
Bright Disease
A historical classification which is no longer used. It described acute glomerulonephritis, acute nephritic syndrome, or acute nephritis. Named for Richard Bright. | 0 | 3.04 | 1 | 0 |
Glomerulonephritis, Lupus
[description not available] | 0 | 3.04 | 1 | 0 |
Autoimmune Diseases
Disorders that are characterized by the production of antibodies that react with host tissues or immune effector cells that are autoreactive to endogenous peptides. | 0 | 3.04 | 1 | 0 |
Glomerulonephritis
Inflammation of the renal glomeruli (KIDNEY GLOMERULUS) that can be classified by the type of glomerular injuries including antibody deposition, complement activation, cellular proliferation, and glomerulosclerosis. These structural and functional abnormalities usually lead to HEMATURIA; PROTEINURIA; HYPERTENSION; and RENAL INSUFFICIENCY. | 0 | 3.04 | 1 | 0 |
Kidney Diseases
Pathological processes of the KIDNEY or its component tissues. | 0 | 3.04 | 1 | 0 |
Lupus Nephritis
Glomerulonephritis associated with autoimmune disease SYSTEMIC LUPUS ERYTHEMATOSUS. Lupus nephritis is histologically classified into 6 classes: class I - normal glomeruli, class II - pure mesangial alterations, class III - focal segmental glomerulonephritis, class IV - diffuse glomerulonephritis, class V - diffuse membranous glomerulonephritis, and class VI - advanced sclerosing glomerulonephritis (The World Health Organization classification 1982). | 0 | 3.04 | 1 | 0 |
Experimental Mammary Neoplasms
[description not available] | 0 | 2.46 | 2 | 0 |
Metastase
[description not available] | 0 | 3.85 | 2 | 1 |
Neoplasm Metastasis
The transfer of a neoplasm from one organ or part of the body to another remote from the primary site. | 0 | 3.85 | 2 | 1 |
Adenocarcinoma, Basal Cell
[description not available] | 0 | 2.05 | 1 | 0 |
Adenocarcinoma
A malignant epithelial tumor with a glandular organization. | 0 | 2.05 | 1 | 0 |
Cancer of Ovary
[description not available] | 0 | 2.05 | 1 | 0 |
Ovarian Neoplasms
Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. | 0 | 2.05 | 1 | 0 |
Innate Inflammatory Response
[description not available] | 0 | 2.05 | 1 | 0 |
Inflammation
A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. | 0 | 2.05 | 1 | 0 |
Benign Neoplasms
[description not available] | 0 | 3.89 | 1 | 0 |
Neoplasms
New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. | 0 | 3.89 | 1 | 0 |
Cancer of Esophagus
[description not available] | 0 | 2.08 | 1 | 0 |
Cancer of Liver
[description not available] | 0 | 2.08 | 1 | 0 |
Esophageal Neoplasms
Tumors or cancer of the ESOPHAGUS. | 0 | 2.08 | 1 | 0 |
Liver Neoplasms
Tumors or cancer of the LIVER. | 0 | 2.08 | 1 | 0 |
Osteogenic Sarcoma
[description not available] | 0 | 2.04 | 1 | 0 |
Invasiveness, Neoplasm
[description not available] | 0 | 2.04 | 1 | 0 |
Osteosarcoma
A sarcoma originating in bone-forming cells, affecting the ends of long bones. It is the most common and most malignant of sarcomas of the bones, and occurs chiefly among 10- to 25-year-old youths. (From Stedman, 25th ed) | 0 | 2.04 | 1 | 0 |